BioCryst Pharmaceuticals
BCRX
#4619
Rank
$1.65 B
Marketcap
$8.01
Share price
-4.30%
Change (1 day)
45.90%
Change (1 year)

Operating Margin for BioCryst Pharmaceuticals (BCRX)

Operating Margin as of October 2024 (TTM): -38.32%

According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -38.32%. At the end of 2023 the company had an Operating Margin of -68.26%.

Operating Margin history for BioCryst Pharmaceuticals from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-68.26%-24.35%
2022-90.24%-21.99%
2021-115.68%-88.73%
2020-1,026.35%360.27%
2019-222.99%-54.52%
2018-490.25%87.7%
2017-261.18%24.82%
2016-209.25%134.73%
2015-89.15%-73.16%
2014-332.08%91.15%
2013-173.72%16.88%
2012-148.64%-48.73%
2011-289.91%434.23%
2010-54.27%194.66%
2009-18.42%-61.65%
2008-48.03%5.99%
2007-45.31%-94.01%
2006-756.28%-95.77%
2005-17,895.15%177.17%
2004-6,456.46%208.3%
2003-2,094.18%98.69%
2002-1,053.98%2258.83%
2001-44.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
10.04%-126.20%๐Ÿ‡บ๐Ÿ‡ธ USA
4.13%-110.78%๐Ÿ‡บ๐Ÿ‡ธ USA
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
-97.60% 154.70%๐Ÿ‡บ๐Ÿ‡ธ USA
5.53%-114.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,054.75% 5,262.08%๐Ÿ‡บ๐Ÿ‡ธ USA
15.88%-141.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
-71.47% 86.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-388.94% 914.98%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.